Cresset Asset Management’s HCW Biologics HCWB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,300
| Closed | -$37.2K | – | 1685 |
|
|
2025
Q1 | $37.2K | Hold |
3,300
| – | – | ﹤0.01% | 1626 |
|
|
2024
Q4 | $58.9K | Hold |
3,300
| – | – | ﹤0.01% | 1612 |
|
|
2024
Q3 | $71.2K | Hold |
3,300
| – | – | ﹤0.01% | 2019 |
|
|
2024
Q2 | $85.4K | Hold |
3,300
| – | – | ﹤0.01% | 1925 |
|
|
2024
Q1 | $231K | Hold |
3,300
| – | – | ﹤0.01% | 1685 |
|
|
2023
Q4 | $162K | Hold |
3,300
| – | – | ﹤0.01% | 1695 |
|
|
2023
Q3 | $251K | Hold |
3,300
| – | – | ﹤0.01% | 1481 |
|
|
2023
Q2 | $286K | Buy |
3,300
+2,861
| +652% | +$248K | ﹤0.01% | 1414 |
|
|
2023
Q1 | $24.6K | Hold |
439
| – | – | ﹤0.01% | 803 |
|
|
2022
Q4 | $33.6K | Hold |
439
| – | – | ﹤0.01% | 692 |
|
|
2022
Q3 | $40K | Hold |
439
| – | – | ﹤0.01% | 861 |
|
|
2022
Q2 | $39K | Hold |
439
| – | – | ﹤0.01% | 917 |
|
|
2022
Q1 | $48K | Buy |
439
+126
| +40% | +$13.8K | ﹤0.01% | 973 |
|
|
2021
Q4 | $29K | Buy |
+313
| New | +$29K | ﹤0.01% | 1115 |
|